Ignite Creation Date:
2024-05-06 @ 2:29 AM
Last Modification Date:
2024-10-26 @ 11:19 AM
Study NCT ID:
NCT02053636
Status:
COMPLETED
Last Update Posted:
2020-01-03
First Post:
2014-01-24
Brief Title:
A Phase II Trial Testing Oral Administration of Lucitanib in Patients With Fibroblast Growth Factor Receptor FGFR1-amplified or Non-amplified Estrogen Receptor Positive Metastatic Breast Cancer
Sponsor:
Institut de Recherches Internationales Servier
Organization:
Servier
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-12
Start Date Type:
None
Primary Completion Date:
2017-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-04-04
Completion Date Type:
ACTUAL
First Submit Date:
2014-01-24
First Submit QC Date:
January 31 2014
Study First Post Date:
2014-02-04
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-07-24
Last Update Post Date:
2020-01-03
Last Update Post Date Type:
ACTUAL